It’s potential is endless. A different kind of CNI, best in class and a BP with a deep pocket will be the suitor for this drug to maximize its potential. This was not much in the radar post p2 where they could have snatched it Much much cheaper than what it is now. The other two indications are the icing in the cake. My guess - it will be Bought In the next 13 months...just speculating.
News 
Market Data 
Discover 
